The patient’s consciousness quickly improved, hematologic damage ameliorated, platelet count increased to 45 × 109/L, anemia improved with hemoglobin reaching 101 g/L, and reexamination showed plasma ADAMTS-13 activity level at 88.79% without any ADAMTS-13 inhibitors. This evidence concerns the gene ADAMTS13 and anemia.